In this review from Neurodegenerative Disease Management, explore current research into visual dysfunction in Alzheimer’s disease pathology.
A lipid has caught the eye of researchers looking to help treat glaucoma and other neurodegenerative diseases.
Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.
Study also reveals differences in the metabolism of macular telangiectasia sufferers that could lead to onset of the disease.
Lauren Pulling highlights some of the key trending topics in neurology and neuroscience from 2016, as well as the top read articles of the year – take a look and let us know your thoughts.
A new retinal imaging technique is the first to identify individual cells; the new technique could aid earlier diagnosis and treatment of vision loss diseases such as glaucoma.
The effects of microgravity on CSF could be responsible for the visual impairment intracranial pressure often seen in long-duration astronauts.
New research has identified how a subset of proteins associated with Alzheimer’s disease can enter and damage retinal cells, and could lead the way to future preventative and treatment strategies for age-related macular degeneration.
A common antihistamine has demonstrated potential efficacy in reversing myelin damage in Multiple Sclerosis patients with optic neuropathy.
Researchers have published the largest network to date of connections between cortical neurons, revealing that neurons carrying out similar functions are more likely to be connected to each other.